Immunohistochemistry showed that CDH23 was expressed in normal pancreatic tissues of control patients and tumor tissues of pancreatic cancer patients; however, the level of CDH23 expression in pancreatic cancer patient tumor tissues was significantly higher compared with normal pancreatic tissues of control patients (Fig. 1A). The gene discussed is CDH23; the disease is pancreatic neoplasm.